Per the MIT Technology Review 2015
Illumina
Juno Therapeutics
OvaScience
Gilead Sciences
Amgen
Bristol-Myers Squibb
Alnylam
Cellectis
Bluebird Bio
Intrexon
Per the MIT Technology Review 2015
Illumina
Juno Therapeutics
OvaScience
Gilead Sciences
Amgen
Bristol-Myers Squibb
Alnylam
Cellectis
Bluebird Bio
Intrexon